Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. For ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Northwestern’s iSeg tool matches expert doctors and finds hidden cancer zones, with clinical rollout expected soon.

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

Bronchiectasis is a chronic lung disease in which the airways (bronchi) become widened and scarred due to repeated inflammation and infection. This damage makes it difficult to clear mucus from the ...

At-home cancer screening tests may help you catch lung cancer early, but studies have yet to show their reliability. Only clinical tests, such as a biopsy or imaging scan, can confirm lung cancer ...

NHS England is set to introduce a pioneering liquid biopsy blood test, offering new hope to lung and breast cancer patients. The innovative test, a world-first, will analyse tumour DNA fragments ...

In contrast, lung cancer in never-smokers is almost exclusively adenocarcinoma – a type which starts in mucus-producing cells – which is now the most common form of lung cancer in both smokers ...

Like other forms of lung cancer, adenocarcinoma is usually diagnosed at an advanced stage. "If there's a 1cm (0.4in) tumour hidden somewhere in your lungs, you won't notice it," says Wicki.

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...